Literature DB >> 11107127

Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.

A Eggert1, M A Grotzer, T J Zuzak, B R Wiewrodt, N Ikegaki, G M Brodeur.   

Abstract

BACKGROUND: Disruption of apoptotic pathways may be involved in tumor formation, regression, and treatment resistance of neuroblastoma (NB). TNF-related apoptosis-inducing ligand (TRAIL) is a potent inducer of apoptosis in cancer cell lines. PROCEDURE: In this study we analyzed the expression and function of TRAIL, its agonistic and antagonistic receptors, and important intracellular signaling elements in 18 NB cell lines.
RESULTS: Semiquantitative RT-PCR revealed that TRAIL-R2 and TRAIL-R3 are the main TRAIL-receptors used by NB cells. Sensitivity to TRAIL-induced apoptosis did not correlate with mRNA expression of TRAIL receptors or cFLIP. Surprisingly, caspase-8 and caspase-10 mRNA was detected in only 5 of 18 NB cell lines. Interestingly, only these five NB cell lines were susceptible to TRAIL-induced apoptosis in a time- and dose-dependent manner.
CONCLUSIONS: Treatment with 5-aza-2'-deoxycytidine restored mRNA expression of caspase-8 and -10 and TRAIL sensitivity of resistant cell lines, suggesting that gene methylation is involved in caspase inactivation. Since many cytotoxic drugs induce caspase-dependent apoptosis, failure to express caspase-8 and/or caspase-10 might be an important mechanism of resistance to chemotherapy in NB. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11107127     DOI: 10.1002/1096-911x(20001201)35:6<603::aid-mpo24>3.0.co;2-1

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  12 in total

Review 1.  Resistance to TRAIL and how to surmount it.

Authors:  Danijela Maksimovic-Ivanic; Stanislava Stosic-Grujicic; Ferdinando Nicoletti; Sanja Mijatovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 2.  Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.

Authors:  Louis Chesler; William A Weiss
Journal:  Semin Cancer Biol       Date:  2011-09-21       Impact factor: 15.707

3.  Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production.

Authors:  Vera Levina; Adele M Marrangoni; Richard DeMarco; Elieser Gorelik; Anna E Lokshin
Journal:  Exp Cell Res       Date:  2008-01-16       Impact factor: 3.905

4.  Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

5.  Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction.

Authors:  Louis Chesler; David D Goldenberg; Rodney Collins; Matt Grimmer; Grace E Kim; Tarik Tihan; Kim Nguyen; Slava Yakovenko; Katherine K Matthay; William A Weiss
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

6.  Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma.

Authors:  Kyung Hwa Lee; Sang Woo Lim; Ho Gun Kim; Dong Yi Kim; Seong Yeob Ryu; Jae Kyun Joo; Jung Chul Kim; Jae Hyuk Lee
Journal:  Langenbecks Arch Surg       Date:  2009-04-07       Impact factor: 3.445

7.  Differential effects of grape seed extract against human colorectal cancer cell lines: the intricate role of death receptors and mitochondria.

Authors:  Molly Derry; Komal Raina; Rajesh Agarwal; Chapla Agarwal
Journal:  Cancer Lett       Date:  2012-12-23       Impact factor: 8.679

Review 8.  The epidemiology of neonatal tumours. Report of an international working group.

Authors:  S W Moore; D Satgé; A J Sasco; A Zimmermann; J Plaschkes
Journal:  Pediatr Surg Int       Date:  2003-09-11       Impact factor: 1.827

9.  Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.

Authors:  Liangran Guo; Li Fan; Jinfeng Ren; Zhiqing Pang; Yulong Ren; Jingwei Li; Ziyi Wen; Yong Qian; Lin Zhang; Hang Ma; Xinguo Jiang
Journal:  Int J Nanomedicine       Date:  2012-03-19

10.  FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.

Authors:  Kathrin Geiger; Judith Hagenbuchner; Martina Rupp; Heidi Fiegl; Consolato Sergi; Bernhard Meister; Ursula Kiechl-Kohlendorfer; Thomas Müller; Michael J Ausserlechner; Petra Obexer
Journal:  Mol Biol Cell       Date:  2012-04-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.